Efficacy and Safety of Avatrombopag in Patients With Thrombocytopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and Safety of Avatrombopag in Patients With Thrombocytopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Published:2019-07-26 Issue: Volume:10 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Li Chunlu,Li Xiaoxuan,Huang Feihong,Yang Jing,Wu Anguo,Wang Long,Qin Dalian,Zou Wenjun,Wu Jianming

Funder

National Natural Science Foundation of China

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference40 articles.

1. Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia;Afdhal;N. Engl. J. Med.,2012

2. Chronic hepatitis C virus related thrombocytopenia to evaluate the effects of E5501 AlirezaM. 2014

3. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy;Br. J. Haematol.,2003

4. A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia;Bussel;Blood,2014

5. American Gastroenterological Association technical review on the management of hepatitis C;Dienstag;Gastroenterology,2006

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombotic Complications in Immune Thrombocytopenia Patients Treated with Avatrombopag;Hematology Reports;2023-09-12

2. Avatrombopag is effective in patients with chemoradiotherapy-induced aplastic anemia: a single-center, retrospective study;Experimental Hematology;2023-01

3. An updated evaluation of avatrombopag for the treatment of chronic immune thrombocytopenia;Expert Review of Clinical Immunology;2022-07-10

4. Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature;Frontiers in Oncology;2021-09-28

5. Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists;Drugs;2021-06-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3